Reminder - Whiting USA Trust II (WHZ) Goes Ex-Dividend Soon

Looking at the universe of stocks we cover at Dividend Channel, on 2/14/14, Whiting USA Trust II (WHZ) will trade ex-dividend, for its quarterly dividend of $0.6514, payable on 3/3/14. As a percentage of WHZ's recent stock price of $13.40, this dividend works out to approximately 4.86%, so look for shares of Whiting USA Trust II to trade 4.86% lower — all else being equal — when WHZ shares open for trading on 2/14/14.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for WHZ, showing historical dividends prior to the most recent $0.6514 declared by Whiting USA Trust II:

WHZ+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from WHZ is likely to continue, and whether the current estimated yield of 19.45% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of WHZ shares, versus its 200 day moving average:

Whiting USA Trust II 200 Day Moving Average Chart

Looking at the chart above, WHZ's low point in its 52 week range is $12.49 per share, with $16.69 as the 52 week high point — that compares with a last trade of $13.38.

In Wednesday trading, Whiting USA Trust II shares are currently up about 0.1% on the day.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says